Lv71
4810 积分 2020-07-11 加入
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
7小时前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
11天前
已完结
Short‐term outcomes of switching from GLP‐1 receptor agonists to tirzepatide in type 2 diabetes: A retrospective, observational study in clinical practice
11天前
已完结
GLP-1 and Calcitonin Concentration in Humans: Lack of Evidence of Calcitonin Release from Sequential Screening in over 5000 Subjects with Type 2 Diabetes or Nondiabetic Obese Subjects Treated with the Human GLP-1 Analog, Liraglutide
13天前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
22天前
已完结
Harnessing Stem Cell Potential for the Treatment of Erectile Function in Men with Diabetes Mellitus: From Preclinical/Clinical Perspectives to Penile Tissue Engineering
1个月前
已完结
Evaluating the prevalence and risk factors of sarcopenia in elderly patients with type 2 diabetes mellitus in a Chinese hospital setting
1个月前
已完结
A New Drug for Obesity: Tirzepatide
2个月前
已完结
Gout and incidence of 12 cardiovascular diseases: a case–control study including 152 663 individuals with gout and 709 981 matched controls
2个月前
已完结
Comparative Efficacy of Tirzepatide, Liraglutide, and Semaglutide in Reduction of Risk of Major Adverse Cardiovascular Events in Patients with Obstructive Sleep Apnoea and Type 2 Diabetes: Real-world Evidence
3个月前
已关闭
皖公网安备34019202002308
